Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Prevest DenproBOM:543363 +0.20%85 Return-on-Tangible-Asset is 16.95% as of Jun. 2026, which is 35% below its 10-year median of 25.95. GuruFocus rates BOM:543363 with a GF Score™ of 85/100 and a GF Value™ of ₹609.46 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Prevest Denpro ranks better than 94.25% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Prevest Denpro's annualizedNet Income for the quarter that ended in Jun. 2026 was ₹225.5 Mil. Prevest Denpro's average total tangible assets for the quarter that ended in Jun. 2026 was ₹1,330.9 Mil. Therefore, Prevest Denpro's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 16.95%.
The historical rank and industry rank for Prevest Denpro's Return-on-Tangible-Asset or its related term are showing as below:
BOM:543363'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 16.68 Med: 25.95 Max: 43.91
Current: 17.68
During the past 8 years, Prevest Denpro's highest Return-on-Tangible-Asset was 43.91%. The lowest was 16.68%. And the median was 25.95%.
BOM:543363's Return-on-Tangible-Asset is ranked better than 94.25% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 0.85
vs BOM:543363: 17.68
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Prevest Denpro Return-on-Tangible-Asset Related Terms
Prevest Denpro Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Prevest Denpro's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543363 vs ISRG, BDX, RMD: Return-on-Tangible-Asset Comparison
For the Medical Instruments & Supplies subindustry, Prevest Denpro's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prevest Denpro Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Prevest Denpro's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Prevest Denpro's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 16.95% mean?
Prevest Denpro (BOM:543363) has a Return-on-Tangible-Asset of 16.95% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Prevest Denpro and its competitors. This is 35% below median its historical median of 25.95. Over the past decade, Prevest Denpro's Return-on-Tangible-Asset has ranged from 16.68 to 43.91. According to the industry distribution chart, Prevest Denpro ranks #49 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 5.8%.
Is Prevest Denpro's Return-on-Tangible-Asset too high?
Prevest Denpro's current Return-on-Tangible-Asset of 16.95% is 35% below median its 10-year median of 25.95. Over the past 10 years, this metric has ranged from a low of 16.68 to a high of 43.91. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.85. Prevest Denpro's value of 16.95% is 1894.1% above this industry median. Based on the distribution chart, Prevest Denpro ranks #49 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Prevest Denpro has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Prevest Denpro's Return-on-Tangible-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Prevest Denpro ranks #49 out of 852 companies for Return-on-Tangible-Asset. This places Prevest Denpro in the top 6% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.85. Prevest Denpro's value of 16.95% is 1894.1% above this benchmark. Historically, Prevest Denpro's own Return-on-Tangible-Asset has ranged from 16.68 to 43.91 over the past decade. While the company's 10-year median is 25.95 vs. the industry median of 0.85, Prevest Denpro has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.85, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prevest Denpro's current Return-on-Tangible-Asset of 16.95% is 1894.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Prevest Denpro and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prevest Denpro's current Return-on-Tangible-Asset is 16.95%, which is 35% below median its own 10-year median of 25.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prevest Denpro stock overvalued right now?
Based on GuruFocus' analysis, Prevest Denpro (BOM:543363) is currently considered Possible Value Trap. The stock's GF Value™ is ₹609.46, compared to a current price of ₹383.55 — trading 37.1% below its estimated fair value. The current Return-on-Tangible-Asset is 16.95%, which is 35% below median its 10-year median of 25.95 and 1894.1% above the Medical Devices & Instruments industry median of 0.85. Prevest Denpro's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Prevest Denpro (BOM:543363), the current Return-on-Tangible-Asset is 16.95% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prevest Denpro (BOM:543363) Overvalued in 2026?
Based on GuruFocus' analysis, Prevest Denpro stock appears to be undervalued.
The current stock price of ₹383.55 is trading 37.1% below its estimated GF Value™ of ₹609.46.
GuruFocus considers Prevest Denpro to be Possible Value Trap.
Key valuation signals for BOM:543363:
Return-on-Tangible-Asset: 16.95% (35% below median its 10-year median of 25.95)
GF Value™: ₹609.46 vs. price of ₹383.55 (37.1% below fair value)
Industry Position: 1894.1% above the Medical Devices & Instruments median (#49 of 852)
No single metric tells the full story. See the BOM:543363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prevest Denpro Ltd develops, manufactures and markets a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. The company's product portfolio covers wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables.
85GF Score
Get the complete analysis for BOM:543363
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543363 has been successfully added to your 
